| Literature DB >> 27879642 |
Nino Cristiano Chilelli1, Eugenio Ragazzi2, Romina Valentini3, Chiara Cosma4, Stefania Ferraresso5, Annunziata Lapolla6, Giovanni Sartore7.
Abstract
BACKGROUND: Chronic intensive exercise is associated with a greater induction of oxidative stress and with an excess of endogenous advanced glycation end-products (AGEs). Curcumin can reduce the accumulation of AGEs in vitro and in animal models. We examined whether supplementation with curcumin and Boswellia serrata (BSE) gum resin for 3 months could affect plasma levels of markers of oxidative stress, inflammation, and glycation in healthy master cyclists.Entities:
Keywords: advanced glycation end-products; curcumin; exercise; inflammation; oxidative stress
Mesh:
Substances:
Year: 2016 PMID: 27879642 PMCID: PMC5133128 DOI: 10.3390/nu8110745
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Basal characteristics of the patients enrolled.
| Group “MD + Curcumin/BSE” | Group “MD” | |||
|---|---|---|---|---|
| ( | ( | |||
| 45 ± 9 | - | 46 ± 8 | - | |
| 72.4 ± 8.0 | 72.4 ± 7.9 | 71.8 ± 9.6 | 70.7 ± 21.7 | |
| 23.7 ± 2.1 | 23.5 ± 2.0 | 23.7 ± 2.8 | 23.0 ± 6.4 | |
| 81 ± 4 | 80 ± 4 | 81 ± 6 | 79 ± 8 | |
| 19 ± 4 | 19 ± 4 | 19 ± 6 | 21 ± 6 | |
MD: Mediterranean diet; BSE: Boswellia serrata extract; BMI: body mass index; FFM: free fat mass; FM: fat mass.
Parameters of inflammation and glyco-/lipo-oxidative stress evaluated in the two groups, before and after therapeutic intervention.
| MD + Curcumin/BSE | MD | |||
|---|---|---|---|---|
| 2.90 ± 0.2 | 2.80 ± 0.2 | 2.60 ± 0.5 | 2.36 ± 1.0 | |
| 1.05 ± 0.67 | 0.68 ± 0.52 ** | 1.24 ± 0.92 | 0.45 ± 0.18 *** | |
| 475.73 ± 141.66 | 328.50 ± 164.49 *** | 430.47 ± 123.59 | 312.34 ± 156.27 *** | |
| 22.42 ± 18.08 | 10.83 ± 6.38 *** | 9.07 ± 4.22 | 9.22 ± 4.07 | |
| 0.16 ± 0.09 | 0.05 ± 0.05 *** | 0.10 ± 0.03 | 0.03 ± 0.01 *** | |
| 17.62 ± 29.76 | 17.55 ± 29.58 | 23.76 ± 53.00 | 41.88 ± 50.69 | |
| 7.29 ± 5.11 | 8.28 ± 5.42 | 7.05 ± 4.61 | 12.67 ± 11.07 * | |
NEFA: non-esterified fatty acids; sRAGE: soluble receptor for advanced glycation end products; AGE: advanced glycation end products; MDA: malondialdehyde; IL-6: interleukine-6; TNFα: tumor necrosis factor α; hs-CRP: high-sensitivity c-reactive protein. *** p < 0.001; ** p < 0.01; * p < 0.05. Student’s t-test for paired data.
Pre–post changes in biomarkers of inflammation and glyco-lipo-oxidation compared between the two groups.
| MD + Curcumin/BSE | MD | ||
|---|---|---|---|
| 0.10 ± 0.2 | 0.24 ± 0.54 | ns | |
| −0.36 ± 0.61 | −0.79 ± 0.89 | ns | |
| −147.23 ± 109.02 | −118.13 ± 117.01 | ns | |
| −11.59 ± 12.49 | 0.15 ± 2.30 | <0.001 | |
| −0.10 ± 0.06 | −0.07 ± 0.03 | <0.02 | |
| −0.07 ± 35.18 | 18.13 ± 59.73 | ns | |
| 0.99 ± 6.88 | 5.62 ± 11.14 | ns |
NEFA: non-esterified fatty acids; sRAGE: soluble receptor for advanced glycation end products; AGE: advanced glycation end products; MDA: malondialdehyde; IL-6: interleukine-6; TNFα: tumor necrosis factor α; hsCRP: c-reactive protein. Variables are presented as the mean (±SD) change from baseline. † Data were compared using Student’s t-test for unpaired data. ns: not statistically significant.